EHV-1 GP2 (C-Term) antibody
Quick Overview for EHV-1 GP2 (C-Term) antibody (ABIN966048)
Target
Reactivity
Host
Clonality
Application
-
-
Binding Specificity
- C-Term
-
Immunogen
- Polyclonal antibody produced in rabbits immunizing with a synthetic peptide corresponding to C-terminal residues of Wild-type equine herpesvirus 1 (EHV-1) glycoprotein, gp2
-
-
-
Restrictions
- For Research Use only
-
-
-
Storage
- 4 °C
-
-
-
: "A Diagnostic Survey of Aborted Equine Fetuses and Stillborn Premature Foals in Denmark." in: Frontiers in veterinary science, Vol. 8, pp. 740621, (2021) (PubMed).
: "Expression of the full-length form of gp2 of equine herpesvirus 1 (EHV-1) completely restores respiratory virulence to the attenuated EHV-1 strain KyA in CBA mice." in: Journal of virology, Vol. 79, Issue 8, pp. 5105-15, (2005) (PubMed).
: "The truncated form of glycoprotein gp2 of equine herpesvirus 1 (EHV-1) vaccine strain KyA is not functionally equivalent to full-length gp2 encoded by EHV-1 wild-type strain RacL11." in: Journal of virology, Vol. 78, Issue 6, pp. 3003-13, (2004) (PubMed).
: "Inoculation with DNA encoding the glycoprotein gp2 reduces severity of equine herpesvirus 1 infection in a mouse respiratory model." in: Archives of virology, Vol. 148, Issue 9, pp. 1805-13, (2003) (PubMed).
-
: "A Diagnostic Survey of Aborted Equine Fetuses and Stillborn Premature Foals in Denmark." in: Frontiers in veterinary science, Vol. 8, pp. 740621, (2021) (PubMed).
-
- EHV-1 GP2
-
Target Type
- Viral Protein
-
Background
- Wild-type equine herpesvirus 1 (EHV-1) strains express a large (250-kDa) glycoprotein, gp2, that is encoded by EUs4 (gene 71) located within the unique short region of the genome. The expression of full-length gp2 restore full respiratory virulence to the attenuated strain.
Target
-